Motor Neurone Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
Conditions: Motor Neuron Disease; Amyotrophic Lateral Sclerosis Intervention: Biological: IC14 Sponsors: Implicit Bioscience; Royal Brisbane and Women's Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2018 Category: Research Source Type: clinical trials
